AI Cracks the Code of Dangerous Blood Sugar Swings in Preterm Babies — and the Answer Lies in the First Minutes of Life
Machine learning has delivered one of its most consequential pediatric findings yet: the strongest warning sign that a premature newborn will slide into dangerous high blood sugar is not found in the womb at all, but in the first minutes after birth. A team of neonatologists and data scientists at the Children’s Hospital of Fudan University in Shanghai, working with colleagues in Shenyang and Guangzhou, deployed continuous glucose monitoring and three layers of statistical and artificial-intelligence analysis to 66 preterm infants and emerged with a ranked map of the forces driving neonatal hyperglycemia. The study, published open access in BMC Pediatrics on 29 August 2026, found that more than a quarter of continuously monitored preterm babies spent time above the clinical glucose danger line of 10 millimoles per liter — and that a depressed Apgar score at one minute of life topped the machine-learned ranking of risk factors. The finding could reshape which infants in intensive care units receive the most vigilant glucose surveillance.
Hyperglycemia is a deceptively quiet threat in the neonatal intensive care unit. Unlike adults, premature infants arrive with an endocrine system that is still under construction: their pancreatic beta cells secrete insulin inefficiently, their tissues respond to the hormone weakly, and the metabolic stress of immature lungs, infection, and life-sustaining nutrition delivered through veins can overwhelm what little glycemic control they possess. When blood glucose climbs above roughly 10 millimoles per liter — about 180 milligrams per deciliter, the threshold used in the new study — sugar spills into the urine, dragging water and electrolytes with it through osmotic diuresis. The consequences cascade: dehydration, unstable blood chemistry, and, epidemiologically, a measurable rise in mortality and morbidity. Clinicians have long recognized the problem, but pinning down who is most at risk has been hampered by a data problem. Standard care relies on intermittent glucose checks — a handful of point-of-care measurements scattered across the day — which can miss the brief spikes that matter most in a body as small and volatile as a preterm infant’s.
The new analysis, led by co-first authors Shiyi Zheng and Ning Liu under the corresponding authorship of Guoqiang Cheng and Liyuan Hu, addressed that blind spot head-on. In a retrospective observational study approved by the hospital’s research ethics committee, the team assembled a cohort of 66 infants born at fewer than 37 weeks of gestation who were hospitalized at the Children’s Hospital of Fudan University between June 2015 and May 2023. Each infant underwent continuous glucose monitoring initiated within seven days of birth during the neonatal period, with written informed consent obtained from legal guardians. Rather than asking the blunt yes-or-no question of whether a baby ever crossed the hyperglycemic threshold, the researchers quantified hyperglycemia frequency — the proportion of CGM time that glucose spent above 10 millimoles per liter. That continuous measure captures both how often and how persistently an infant’s metabolism strays into the danger zone, turning a binary diagnosis into a graded, information-rich phenotype that statistical models can dissect.
Continuous glucose monitoring is what makes such a phenotype measurable at all. A CGM sensor is a hair-thin filament inserted just beneath the skin that samples glucose in the interstitial fluid — the liquid bathing the body’s cells — every few minutes, around the clock. Where an intermittent glucose check offers a snapshot, a multi-day CGM trace offers something closer to a metabolic film, capturing nocturnal swings, post-feeding surges, and transient excursions that a fingerstick schedule would almost certainly miss. For an infant whose blood volume is tiny and whose glucose can shift within minutes, that temporal resolution is not a luxury; it is the difference between seeing the disease and missing it. The technology, long standard in adult diabetes care, has been migrating into neonatology, and datasets like the one assembled in Shanghai — thousands upon thousands of glucose readings woven together with clinical records — are exactly the kind of high-resolution, heterogeneous data that modern machine-learning methods were built to exploit.
Once the data were assembled, the team ran them through three complementary analytical engines. First, pairwise correlation analysis scanned maternal, neonatal, and postnatal variables for simple statistical associations with hyperglycemia frequency, flagging candidates such as neonatal respiratory distress syndrome, metabolic acidosis, maternal anemia, Apgar scores, and maternal age. Second, structural equation modeling, or SEM — a framework from covariance-structure analysis that tests whether observed variables hang together under hypothesized latent constructs — let the researchers compare competing causal architectures in which maternal, neonatal, or postnatal factors served as the upstream drivers of glycemic instability. Third, and most distinctively, the study deployed a histogram-based gradient boosting regression tree, or HGBRT, a machine-learning algorithm that builds an ensemble of decision trees in sequence, each new tree correcting the residual errors of its predecessors, with features binned into histograms to speed training on large tabular datasets. To make the ensemble’s verdicts interpretable, the researchers applied SHAP-based feature ranking, a technique borrowed from cooperative game theory that assigns each input variable its marginal contribution to every individual prediction.
The headline result is a sobering prevalence figure: hyperglycemia above 10 millimoles per liter was detected in 17 of the 66 continuously monitored preterm neonates, or 25.76 percent — more than one in four. The correlation analysis then drew a constellation of significant links. Babies who showed higher hyperglycemia frequency were more likely to have suffered neonatal respiratory distress syndrome, a lung-immaturity disorder that floods the earliest days of life with inflammation, oxygen therapy, and physiological stress. Metabolic acidosis, a state in which the blood turns dangerously acidic, tracked with glucose excursions, as did maternal anemia — hinting that the oxygen-carrying capacity of maternal blood may echo in a newborn’s metabolic stability. Lower Apgar scores at both one and five minutes — the standard ten-point assessment of a newborn’s heart rate, breathing, muscle tone, reflex response, and skin color — correlated with hyperglycemia frequency, and older maternal age emerged as a consistent, if less intuitive, companion of risk.
When the HGBRT algorithm delivered its ranking, the picture sharpened. The single most influential risk factor for hyperglycemia frequency was a lower Apgar score at one minute after birth — the classical bedside snapshot of how depressed a newborn is at the moment of delivery. Infection followed close behind, reinforcing a long-standing suspicion that inflammatory stress destabilizes neonatal glucose metabolism. Lower Apgar score at five minutes, lower gestational age, higher parity, and higher maternal age completed the top tier of predictors. The SHAP ranking does more than order variables by importance; it quantifies, for each individual prediction, how much each feature pushed the model’s output up or down, exposing interaction effects that linear statistics would smooth away. In practical terms, the machine had learned something clinically legible: a preterm infant who is born in poor condition, who fights infection, who arrives earlier than expected, and whose mother is older carries a compounding glycemic risk profile that a routine chart review might overlook until glucose actually spikes.
The structural equation modeling added the causal twist that gives the study its punch. When maternal, neonatal, and postnatal factors were modeled as competing upstream constructs, it was the postnatal pathway — the events unfolding in and after the delivery room — that emerged as causally associated with higher hyperglycemia frequency, rather than maternal or neonatal factors alone. Integrating all three analytical strands, the team concluded that postnatal factors, including lower Apgar scores at one and five minutes after birth and higher maternal age, significantly contributed to higher hyperglycemia frequency in the neonatal period. The interpretation is subtle but consequential: these variables do not merely correlate with glucose instability; within the model’s architecture they sit upstream in the causal chain, propagating their influence through the baby’s subsequent clinical course. That framing shifts the clinical spotlight from the fixed prenatal history toward the window clinicians can actually watch and influence — the days when infection takes hold, respiratory support is tuned, and every hour of unstable glucose leaves its mark.
For neonatologists, the translational message is direct: preterm infants bearing these postnatal risk factors should be prioritized for continuous glucose monitoring to tighten hyperglycemia surveillance. In an era when CGM sensors can stream glucose values to bedside monitors and trigger automated alerts, the risk ranking offers a rational triage rule. A baby with depressed Apgar scores, a confirmed infection, and early respiratory distress is precisely the patient whose metabolic trajectory warrants the closest watch — and, when glucose begins to climb, the earliest decisions about fluid composition, glucose infusion rates, feeding strategy, and, in severe cases, insulin therapy. The authors also point to the broader promise of embedding machine-learning risk scores directly into monitoring platforms, so that an algorithm’s ranked warnings travel alongside the sensor’s raw numbers. Such a pairing would move neonatal glycemic care from reactive correction toward prospective prevention — an orientation that mirrors the broader trajectory of precision medicine across pediatrics.
The researchers are candid about the study’s boundaries. It is retrospective, single-center, and built on a modest cohort of 66 infants drawn from one major Chinese children’s hospital, so the HGBRT and SEM findings will need validation in larger, multi-ethnic, prospectively recruited populations before they can shape universal screening protocols. Structural equation modeling, however sophisticated, tests hypothesized structures rather than proving causation in the experimental sense. Yet the methodological triangulation — correlation, causal modeling, and machine learning converging on one coherent story, supported by funding from China’s National Natural Science Foundation and National Key R&D Program — is itself a template for how clinical data science should work. Published as an open-access paper in BMC Pediatrics, with the accepted, peer-reviewed version carrying a permanent DOI ahead of final production edits, the study invites intensive care units worldwide to ask a simple question with far-reaching consequences: which of our smallest patients are wearing the sensor that could spare them a silent, sugar-fueled crisis? For one in four preterm babies, the answer, increasingly, is the ones born fighting.
Subject of Research: Identification of risk factors for neonatal hyperglycemia in preterm infants using continuous glucose monitoring, structural equation modeling, and machine learning
Subject of Research: Medicine
Article Title: Identification of risk factors for hyperglycemia during the neonatal period in preterm infants: a machine learning-based study
Article References: Zheng, S., Liu, N., Wang, J., Wang, X., Zhang, P., Lu, C., Wang, L., Zhou, W., Cheng, G., & Hu, L. (2026). Identification of risk factors for hyperglycemia during the neonatal period in preterm infants: a machine learning-based study. BMC Pediatrics. https://doi.org/10.1186/s12887-026-07604-w
Image Credits: AI Generated
DOI: 10.1186/s12887-026-07604-w
Keywords: Continuous glucose monitoring, Machine learning, Hyperglycemia, Preterm neonates, Structural equation modeling, Apgar score, Histogram-based gradient boosting, SHAP, Neonatal respiratory distress syndrome, Gestational age
Cite Scienmag News
APA
MLA
Chicago
Elowen H. (August 29, 2026). Machine learning reveals risk factors for high blood sugar in preterm infants. Scienmag. https://scienmag.com/machine-learning-reveals-risk-factors-for-high-blood-sugar-in-preterm-infants/
Elowen H. “Machine learning reveals risk factors for high blood sugar in preterm infants.” Scienmag, 29 August 2026, https://scienmag.com/machine-learning-reveals-risk-factors-for-high-blood-sugar-in-preterm-infants/. Accessed 29 August 2026.
Elowen H. “Machine learning reveals risk factors for high blood sugar in preterm infants.” Scienmag. August 29, 2026. https://scienmag.com/machine-learning-reveals-risk-factors-for-high-blood-sugar-in-preterm-infants/
Copy citation
Download RIS
Tags: AI analysis of neonatal risk factorsAI-driven neonatal risk assessmentApgar score importance in neonatal blood sugarApgar score significance in preterm infantscontinuous glucose monitoring in neonatal carecontinuous glucose monitoring in preemiesdata-driven approaches to preterm infant careearly detection of hyperglycemia in preterm babiesearly life indicators of neonatal hyperglycemiaearly life predictors of neonatal blood sugar swingsearly prediction of high blood sugar in preemiesmachine learning in pediatric healthcaremachine learning neonatal hyperglycemia predictionneonatal hyperglycemia clinical implicationsneonatal hyperglycemia detection using machine learningneonatal intensive care blood sugar managementneonatal intensive care unit glucose managementpediatric AI for neonatal healthpediatric hyperglycemia risk factorspredictive analytics in neonatal intensive carepreterm infant blood sugar risk factorsrisk factors for preterm infant glucose swingsstatistical modeling of neonatal hyperglycemia
